Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 2

    Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb

    Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb

    Medical Dialogues Bureau11 April 2020 1:56 PM IST
    USA: A federal judge increased to $1.2 billion the damages that Gilead Sciences Inc must pay to Bristol-Myers Squibb Co in a patent infringement...
    Zydus gets USFDA tentative nod for Empagliflozin Tablets

    Zydus gets USFDA tentative nod for Empagliflozin Tablets

    Medical Dialogues Bureau11 April 2020 12:17 PM IST
    Ahmedabad: Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD:...
    Dr Reddys Labs receives EIR for Nalgonda-based API plant

    Dr Reddy's Labs receives EIR for Nalgonda-based API plant

    Medical Dialogues Bureau11 April 2020 11:03 AM IST
    New Delhi: Dr Reddy's Laboratories has announced that it has received an establishment inspection report (EIR) from the US health regulator for its...
    Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

    Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

    Medical Dialogues Bureau11 April 2020 9:30 AM IST
    Paris: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could...
    Centre steps up efforts to ensure availability of medical oxygen

    Centre steps up efforts to ensure availability of medical oxygen

    Medical Dialogues Bureau11 April 2020 9:00 AM IST
    Thiruvananthapuram: After seeing several countries facing problem due to lack of medical oxygen, the Indian government is making all possible efforts...
    Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules

    Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules

    Medical Dialogues Bureau10 April 2020 12:01 PM IST
    Butalbital, Acetaminophen and Caffeine Capsules are used for the relief of the symptom complex of tension headache.
    Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol

    Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol

    Medical Dialogues Bureau10 April 2020 10:00 AM IST
    Mumbai: Cipla Limited has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate...
    No need to panic over availability of PPE: Health ministry

    No need to panic over availability of PPE: Health ministry

    Medical Dialogues Bureau10 April 2020 9:00 AM IST
    New Delhi: The Union health ministry on Thursday said there is no need to panic over the availability of COVID-19 personal protective equipment (PPE),...
    US pharmacies authorized to test for COVID-19

    US pharmacies authorized to test for COVID-19

    Medical Dialogues Bureau10 April 2020 9:00 AM IST
    Washington: The US authorized pharmacies on Wednesday to carry out tests for the coronavirus, including newly developed antibody tests that detect...
    Zydus gets USFDA final approval for Imatinib Mesylate Tablets

    Zydus gets USFDA final approval for Imatinib Mesylate Tablets

    Medical Dialogues Bureau9 April 2020 1:01 PM IST
    Ahmedabad: Zydus Cadila has received final approval from the USFDA to market Imatinib Mesylate Tablets, 100 mg and 400 mg. (US RLD: Gleevec®...
    With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India

    With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India

    Medical Dialogues Bureau9 April 2020 12:30 PM IST
    New Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative...
    Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT

    Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT

    Medical Dialogues Bureau9 April 2020 10:00 AM IST
    New York: President Donald Trump, who has aggressively promoted the use of hydroxychloroquine to treat coronavirus patients in and has asked India to...
    PrevNext

    Popular Stories

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok